Gabapentin
Product Images NDC 42495-556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42495-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westwood Manufacturing, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6ca04cda-figure-01 (Gabapentin Capsules Usp Goa Goa 1)

FDA Label Image

6ca04cda-figure-02 (Gabapentin Capsules Usp Goa Goa 2)

6ca04cda-figure-02 (Gabapentin Capsules Usp Goa Goa 2)
This is a graph displaying the results of a study on the effectiveness of Gabapentin at different doses for a fixed period. The X-axis represents the weeks of the study, while the Y-axis shows the effectiveness of the drug. The graph shows that the group taking 2400mg/day of Gabapentin experienced the greatest effectiveness compared to the placebo group and those taking 1800mg/day. There are significant differences between the groups (p<001).*
FDA Label Image

6ca04cda-figure-03 (Gabapentin Capsules Usp Goa Goa 3)

6ca04cda-figure-03 (Gabapentin Capsules Usp Goa Goa 3)
This document appears to be a graph or chart showing the percentage of responders at an endpoint, labeled with values of 12% and 14%. The letters "PBO" appear at the bottom of the graph, potentially indicating a drug or treatment being evaluated.*
FDA Label Image

6ca04cda-figure-04 (Gabapentin Capsules Usp Goa Goa 4)

FDA Label Image

6ca04cda-figure-05 (Gabapentin Capsules Usp Goa Goa 5)

6ca04cda-figure-05 (Gabapentin Capsules Usp Goa Goa 5)
The text represents a graph showing the mean pain score of individuals across eight weeks. The x-axis represents the week, while the y-axis represents the mean pain score. The graph compares a placebo treatment with a 3600 mg/day dose of Gabapentin.*
FDA Label Image

6ca04cda-figure-06 (Gabapentin Capsules Usp Goa Goa 6)

FDA Label Image

6ca04cda-figure-07 (Gabapentin Capsules Usp Goa Goa 7)

FDA Label Image

6ca04cda-figure-08 (Gabapentin Capsules Usp Goa Goa 8)

FDA Label Image

Image Description (Snip Gaba)

Image Description (Snip Gaba)
This is a description of a medication called Gabapentin, which is typically taken at a dosage of 300mg. The medication comes in a bottle containing 30 capsules, and there is an insert with further information about the drug. The text includes information about the storage conditions, lot number, and expiration date of the medication. It also notes that the medication is only available with a prescription. The medication was repackaged by Westwood Manufacturing, located in Richmond VA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.